Breast cancer screening

References

• Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975–2001, with a special feature regarding survival. Cancer 2004; 101 (1): 3–27
   PubMed Web of Science ®Google Scholar
• Peto R, Boreham J, Clarke M, et al. UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years. Lancet 2000; 355(9217): 1822
   PubMed Web of Science ®Google Scholar
• Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002; 94(20): 1546–54
   PubMedGoogle Scholar
• Stat bite: Incidence of in situ and invasive breast cancer by age, 1975–2001. J Natl Cancer Inst 2004; 96(20): 1496
   Google Scholar
• Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Databases: Incidence-SEER 13 regs public-use, Nov 2004 sub for expanded races (1992–2002) and Incidence-SEER 13 regs excluding AK public-use, Nov 2004 sub for Hispanics (1992–2002). National Cancer Institute, Division of Cancer Control and Populations Sciences, Surveillance Research Program, Cancer Statistics Branch, released April 2005, based on the November 2004 submission. Available at: http://www.seer.cancer.gov. Accessed Jun 13, 2005.
   Google Scholar
• Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55(2): 74–108
   Google Scholar
• Freudenheim JL, Marshall JR, Vena JE, et al. Premenopausal breast cancer risk and intake of vegetables, fruits, and related nutrients. J Natl Cancer Inst 1996; 88(6): 340–8
   PubMedGoogle Scholar
• Shin MH, Holmes MD, Hankinson SE, et al. Intake of dairy products, calcium, and vitamin D and risk of breast cancer. J Natl Cancer Inst 2002; 94(17): 1301–11
   PubMedGoogle Scholar
• Cho E, Spiegelman D, Hunter DJ, et al. Premenopausal fat intake and risk of breast cancer. J Natl Cancer Inst 2003; 95(14): 1079–85
   Google Scholar
• Knight JA, Martin LJ, Greenberg CV, et al. Macronutrient intake and change in mammographic density at menopause: results from a randomized trial. Cancer Epidemiol Biomarkers Prev 1999; 8(2): 123–8
   Google Scholar
• Bonner MR, Han D, Nie J, et al. Breast cancer risk and exposure in early life to polycyclic aromatic hydrocarbons using total suspended particulates as a proxy measure. Cancer Epidemiol Biomarkers Prev 2005; 14(1): 53–60
   PubMed Web of Science ®Google Scholar
• Sigurdson AJ, Ron E. Cosmic radiation exposure and cancer risk among flight crew. Cancer Invest 2004; 22(5): 743–61
   PubMed Web of Science ®Google Scholar
• Tsai SP, Chen VW, Fox EE, et al. Cancer incidence among refinery and petrochemical employees in Louisiana, 1983–1999. Ann Epidemiol 2004; 14(9): 722–30
   PubMed Web of Science ®Google Scholar
• Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001; 344(4): 276–85 [Erratum, N Engl J Med 2001;344(23): 1804]
   PubMed Web of Science ®Google Scholar
• Fletcher SW, Elmore JG. Clinical practice. Mammographic screening for breast cancer. N Engl J Med 2003; 348(17): 1672–80
   PubMedGoogle Scholar
• Humphrey LL, Helfand M, Chan BK, et al. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137(5 Part 1): 347–60
   PubMed Web of Science ®Google Scholar
• ACOG practice bulletin. Breast cancer screening. No. 42, April 2003. Int J Gynaecol Obstet 2003; 81(3): 313–23
   Google Scholar
• Bobo JK, Lee NC, Thames SF. Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. J Natl Cancer Inst 2000; 92(12): 971–6
   Google Scholar
• Oestreicher N, White E, Lehman CD, et al. Predictors of sensitivity of clinical breast examination (CBE). Breast Cancer Res Treat 2002; 76(1): 73–81
   Google Scholar
• Barton MB, Harris R, Fletcher SW. The rational clinical examination. Does this patient have breast cancer? The screening clinical breast examination: should it be done? How? JAMA 1999; 282(13): 1270–80
   PubMed Web of Science ®Google Scholar
• Meissner HI, Breen N, Yabroff KR. Whatever happened to clinical breast examinations? Am J Prev Med 2003; 25(3): 259–63
   PubMedGoogle Scholar
• Kerlikowske K, Grady D, Rubin SM, et al. Efficacy of screening mammography. A meta-analysis. JAMA 1995; 273(2): 149–54
   Google Scholar
• Smith-Bindman R, Chu PW, Miglioretti DL, et al. Comparison of screening mammography in the United States and the United Kingdom. JAMA 2003; 290(16): 2129–37 [Erratum, JAMA 2004; 291(7): 824]
   PubMed Web of Science ®Google Scholar
• Elmore JG, Nakano CY, Koepsell TD, et al. International variation in screening mammography interpretations in community-based programs. J Natl Cancer Inst 2003; 95(18): 1384–93
   PubMedGoogle Scholar
• Elmore JG, Barton MB, Moceri VM, et al. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998; 338(16): 1089–96
   PubMed Web of Science ®Google Scholar
• Barton MB, Morley DS, Moore S, et al. Decreasing women's anxieties after abnormal mammograms: a controlled trial. J Natl Cancer Inst 2004; 96(7): 529–38
   PubMedGoogle Scholar
• Burstein HJ, Polyak K, Wong JS, et al. Ductal carcinoma in situ of the breast. N Engl J Med 2004; 350(14): 1430–41
   PubMed Web of Science ®Google Scholar
• Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000; 355(9198): 129–34
   PubMed Web of Science ®Google Scholar
• Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001; 358(9290): 1340–2
   PubMed Web of Science ®Google Scholar
• White E, Velentgas P, Mandelson MT, et al. Variation in mammographic breast density by time in menstrual cycle among women aged 40–49 years. J Natl Cancer Inst 1998; 90(12): 906–10
   Google Scholar
• Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003; 138(3): 168–75 [Erratum, Ann Intern Med 2003; 138(9): 771]
   PubMed Web of Science ®Google Scholar
• Gur D, Sumkin JH, Rockette HE, et al. Changes in breast cancer detection and mammography recall rates after the introduction of a computer- aided detection system. J Natl Cancer Inst 2004; 96(3): 185–90
   Google Scholar
• Kriege M, Brekelmans CT, Boetes C, et al; Magnetic Resonance Imaging Screening Study Group. Efficacy of MRI and mammography for breast- cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004; 351(5): 427–37
   PubMed Web of Science ®Google Scholar
• Podo F, Sardanelli F, Canese R, et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 2002; 21(3 Suppl): 115–24
   Google Scholar
• Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, et al. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 2000; 63(1): 53–60
   Google Scholar
• Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCAJ and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004; 292(11): 1317–25
   PubMed Web of Science ®Google Scholar
• Morris EA, Liberman L, Ballon DJ, et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 2003; 181(3): 619–26
   PubMed Web of Science ®Google Scholar